
Lycojana
January 14, 2025
FARKUF- BR
January 14, 2025
of Pharmaceutical Tablets, Syrup, Ointment, Capsules pharmaceuticals.
Product Description
FARKUF-AM Syrup is a combination formulation containing Ambroxol I.P. 15 mg, Terbutaline I.P. 1.25 mg, Guaiphenesin I.P. 50 mg, and Menthol 2.5 mg, used for the treatment of productive (wet) cough and chest congestion.
Ambroxol is a mucolytic agent that helps break down thick mucus, making it easier to expel. Guaiphenesin acts as an expectorant, promoting mucus clearance from the airways. Terbutaline is a bronchodilator that relaxes airway muscles and improves breathing, while Menthol provides a soothing and cooling effect on the throat. This combination ensures effective relief from cough and congestion.
Key Benefits
- Helps relieve wet (productive) cough
- Loosens and clears mucus from the airways
- Eases chest congestion and breathing difficulty
- Provides soothing effect on throat irritation
- Improves respiratory comfort
Key Ingredients
- Ambroxol I.P. 15 mg – Mucolytic agent
- Terbutaline I.P. 1.25 mg – Bronchodilator
- Guaiphenesin I.P. 50 mg – Expectorant
- Menthol 2.5 mg – Soothing agent
Indications
- Productive cough
- Chest congestion
- Bronchitis
- Respiratory tract infections with mucus
- Breathing difficulty due to mucus buildup
Dosage / Usage
- Take as directed by a physician
- Shake well before use
- Use a measuring cup for accurate dosage
Precautions
- Use under medical supervision
- May cause mild side effects like nausea or dizziness
- Use cautiously in patients with heart conditions
- Not recommended during pregnancy without advice
- Do not exceed recommended dose
- Store in a cool and dry place
- Keep out of reach of children
| Packing |
|---|





